Mechanism of Pharmacological Action
The pharmacological effect of the drug is based on its ability to target inflammatory enzymes. At low doses, Meloxicamum exhibits selective COX-2 inhibition, which reduces the severity of inflammatory responses and pain.
Pharmacokinetics and Dosing Regimen
A key feature of the drug is its prolonged half-life. This pharmacokinetic property ensures a sustained therapeutic effect and allows for a convenient dosing regimen: administration only once a day.
Clinical Indications
The drug is used in rheumatology and orthopedics for the treatment of chronic joint and spinal disorders. Main indications include:
- Rheumatoid arthritis;
- Ankylosing spondylitis;
- Osteoarthritis.
Safety Profile and Side Effects
The use of Meloxicamum requires safety monitoring due to specific risks:
- A high incidence of gastrointestinal adverse effects has been documented.
- The prolonged half-life creates an increased risk of cumulation (accumulation) of the active substance in the body.
- Drug accumulation directly leads to the development of undesirable toxic effects.